The Nasdaq currently exhibits a clear oscillation pattern, with both upward and downward movement potentials compressed. Instead of fixating on its uneventful trend, consider switching tracks. The biotechnology sector follows a different rhythm—it maintains long-term alignment with the S&P and Nasdaq but offers more ample short-term volatility, which is exactly what traders seeking participation need. From a technical perspective, the biotech sector's formation is quite solid, currently in the mid-stage of a main upward wave, with no obvious top characteristics yet. Rather than being forced to dollar-cost average into the Nasdaq during low volatility, it might be better to find a rhythm within the biotech sector. Of course, if you already hold positions in the Nasdaq, long-term dollar-cost averaging is also fine.